Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Hapvida and Intermedica continue M&A binge through crisis

Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country. 

Eugin process enters second-round – but will COVID impact valuation?

Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?

French and Italian hospital groups’ diverging recovery reflects COVID experience

August activity levels for France's second-largest hospital group Elsan were ahead of 2019, while Italy's largest player San Donato is still 30% down due to a more gradual restart of electives and stricter contagion control in Lombardy, HBI can reveal. The cautiousness reflects just how hard-hit the region was.

Spire’s payor mix turned on its head in Q2

UK hospital group Spire Healthcare became a majority NHS-funded provider for the first time ever during the first half of 2020 as it became an extension of the public health system, its H1 2020 results reveal. What are the implications and how do you value a company in such unprecedented circumstances? We talk to an analyst. 

PWC on M&A drivers in Spanish healthcare sector

The Spanish private healthcare market has been one of Europe's most attractive for institutional investors of late with strong organic and inorganic growth opportunities. PWC Spain's deals leader for Healthcare & Pharma Jose Zarzalejos talks us through the drivers, movers and shakers in the six main sub-sectors: hospitals, imaging, oncology, care homes, IVF and dentistry.

Find Us